The Efficacy and Safety of Tipapkinogen Sovacivec Therapeutic HPV Vaccine in Cervical Intraepithelial Neoplasia Grades 2 and 3: Randomized Controlled Phase II Trial with 2.5 Years of Follow-up

Academic Article


  • On a global scale, cervical cancer comprises approximately 80% of human papillomavirus (HPV)-associated cancers. These cancers are most often treated surgically, and despite a high surgical success and vaccine prevention rate; there exists a need for nonsurgical, nonablative techniques to treat HPV-associated cancers.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Harper DM; Nieminen P; Donders G; Einstein MH; Garcia F; Huh WK; Stoler MH; Glavini K; Attley G; Limacher JM
  • Start Page

  • 529
  • End Page

  • 530
  • Volume

  • 74
  • Issue

  • 9